New evidence
Chanca Piedra as an add-on to shockwave therapy improved stone clearance for lower pole kidney stones — but this is the first systematic review on the combo, so the evidence is still early and the dose wasn't specified.
This systematic review is the first to compile data on Chanca Piedra specifically as an adjunct to ESWL for lower pole stones, making the finding promising but preliminary — the exact dose remains unknown, and the overall body of evidence on this pairing is still thin.
A systematic review found that adding Chanca Piedra (Phyllanthus niruri) to standard shockwave lithotripsy may help clear kidney stones located in the lower pole of the kidney, with consistent long-term safety data. However, the review didn't specify the dose used, and because this is the first indexed study on this specific combination, the results should be treated as early evidence rather than a settled recommendation. Adverse events were reported overall, but the review did not detail them, so the trade-off isn't fully clear.
Where this fits in the evidence
This is among the first studies we've indexed on Chanca Piedra for Improved Stone-Free State — treat it as an early signal until more research accumulates.
The study
Phyllanthus niruri in the management of nephrolithiasis: A systematic review of the literature.
- Systematic Review
- 2025-07
- Actas urologicas espanolas
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.